ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 6.38
+0.38 (6.33%)
At close: Dec 5, 2025
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 32.07 million as of December 5, 2025. Its market cap has increased by 415.18% in one year.
Market Cap
32.07M
Enterprise Value
31.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.38
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 32.07M, a decrease of -11.19%. That is a compound annual growth rate of -0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 32.07M | 539.17% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | 33.40M | 24.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |